
    
      The aim of this protocol is to collect serum and genotype from normo-ovulatory women with a
      regular indication for IVF/ICSI that can aid further research into the investigators
      principle lines of research which include improving performance ART treatment , limiting
      pregnancy complications, and improving offspring health.
    
  